A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialDominick J. Angiolillo, Mark B. Effron, J J Badimón et al.|European Heart Journal|2011Cited by 182
The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and PrasugrelPaul A. Gurbel, Brian Baker, Kevin P. Bliden et al.|Journal of the American College of Cardiology|2013Cited by 139
Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-Treated Patients With Stable Coronary DiseaseMatthew J. Price, Dominick J. Angiolillo, James Walder et al.|Journal of the American College of Cardiology|2012Cited by 116
The Onset of Inhibition of Platelet Aggregation With Prasugrel Compared With Clopidogrel Loading Doses Using Gatekeeping Analysis of Integrated Clinical Pharmacology DataBaojin Zhu, Kenneth J. Winters, Mark B. Effron et al.|Journal of Cardiovascular Pharmacology|2011Cited by 20
A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrelIsabell Bernlochner, Dirk Sibbing, Tanja Morath et al.|Platelets|2012Cited by 10